Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer Registration, Molecular Marker Status, and Adherence to the WHO 2016 Classification of Pathology Reports for Glioma Diagnosed during 2017-2019 in Belgium.

Pathobiology : journal of immunopathology, molecular and cellular biology - 1 Jan 2023

Vanhauwaert Dimitri, Pinson Harry, Vanschoenbeek Katrijn, Dedeurwaerdere Franceska, De Gendt Cindy, Boterberg Tom, De Vleeschouwer Steven

Abstract excerpt

INTRODUCTION: The objective of this study was to cross-check and, if necessary, adjust registered ICD-O-3 topography and morphology codes with the findings in pathology reports available at the Belgian Cancer Registry (BCR) for glioma patients. Additionally, integration of molecular markers in the pathological diagnosis and concordance with WHO 2016 classification is investigated. METHODS: Since information...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Belgium
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brain Neoplasms

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to World Health Organization

Source

Identifiers

PMID: 36702113
DOI: 10.1159/000529320

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer Registration, Molecular Marker Status, and Adherence to the WHO 2016 Classification of Pathology Reports for Glioma Diagnosed during 2017-2019 in Belgium.PMID 36702113Read ↗

Updating TCGA glioma classification through integration of molecular profiling data following the 2016 and 2021 WHO guidelinesSemantic proximity Read ↗

Real-life implementation of molecular criteria for diagnosing gliomas according to 2021 WHO Classification: a national survey from the Italian Association of Neuro-Oncology and Society of Neurosurgery.Semantic proximity Read ↗

Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016Semantic proximity Read ↗

Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.Semantic proximity Read ↗

[Analysis of the clinical impact of the diagnostic reclassification of brain gliomas according to the World Health Organization classification (2016)].Semantic proximity Read ↗

An analysis of prognostic factors in a cohort of low-grade gliomas and degree of consistency between RTOG and EORTC scores.Semantic proximity Read ↗

Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT- NOW Update 3 signature: real-word single center experienceSemantic proximity Read ↗

Utility of gene tumor expression of<i>VEGF, FOXM1*3</i>and<i>CD-133</i>on diagnosis and prognosis of brain gliomasSemantic proximity Read ↗

Protocol for the Tessa Jowell BRAIN MATRIX Platform StudySemantic proximity Read ↗

Brain Tumor Classification by Methylation ProfileSemantic proximity Read ↗

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Tumors of the Central Nervous System.Semantic proximity Read ↗

Brain tumour diagnostics using a DNA methylation‐based classifier as a diagnostic support toolSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.